Optimizing Prevention of Recurrent Urinary Tract Infections in Older Patients with Frailty

Area of Science:

• Gerontology
• Infectious Diseases
• Pharmacology

Background:

• Frailty exacerbates risks of infection and adverse drug reactions in older adults.
• Recurrent urinary tract infections (rUTIs) are prevalent and burdensome in frail elderly individuals.
• Frail populations are underrepresented in clinical research for rUTI prevention.

Purpose of the Study:

• To review current evidence on rUTI prevention strategies for older adults with frailty.
• To explore frailty assessment tools and their impact on infection risk and intervention effectiveness.
• To guide clinical decision-making for rUTI prevention in this vulnerable group.

Main Methods:

• Literature review of current evidence on rUTI prevention in frail older persons.
• Analysis of frailty assessment tools and their role in infection risk.
• Evaluation of non-pharmacological and pharmacological interventions for rUTI prevention.

Main Results:

• Non-pharmacological strategies (continence management, reduced catheter use, hydration, carer education) are foundational.
• Vaginal estrogen is the most supported pharmacological option for postmenopausal women.
• Evidence for cranberry, D-mannose, and probiotics is inconsistent; methenamine hippurate shows promise; antibiotics carry risks.

Conclusions:

• rUTI prevention in frail older adults requires individualized risk assessment and careful benefit-harm evaluation.
• Non-pharmacological approaches and methenamine hippurate are key considerations.
• Urgent research is needed to develop evidence-based prevention strategies for this population.